Research & Press

At Bodyport, we take heart health seriously and apply the appropriate technological rigor and clinical expertise to ensure our products and services meet industry standards. Real-world evidence is important to us and our partners. And we know it matters to you — see for yourself.

November 6, 2024
May 25, 2023
Research
Press

Study to Measure Accuracy of Unique Index for Early, Noninvasive Prediction of Worsening Heart Failure

November 6, 2024
August 9, 2022
Research
Press

Bodyport Receives FDA Clearance for the Bodyport Cardiac Scale

November 6, 2024
August 2, 2022
Research
Press

Assessing Heart Function and Fluid Status with Cardiac Scales: Interview with John Lipman, CEO, and Corey Centen, Founder, Bodyport

November 6, 2024
June 23, 2022
Research
Press

Bodyport Announces Appointment of Jim Pursley to Board of Directors

November 6, 2024
June 23, 2022
Research
Press

Wearables are collecting a flood of data. An ambitious new study of pregnancy aims to prove that’s valuable for health

November 6, 2024
June 15, 2022
Research
Press

Bodyport Appoints John Lipman as Chief Executive Officer

November 6, 2024
April 8, 2022
Research
Press

Feasibility of a Cardiac Scale in Measuring Blood Pressure, Journal of Cardiovascular Translational Research, JCTR

November 6, 2024
March 8, 2022
Research
Press

Outpatient heart failure monitoring with a novel cardiac scale: tracking volume status, Journal of American College of Cardiology, JACC

November 6, 2024
December 7, 2021
Research
Press

Noninvasive Scale Measurement of Stroke Volume and Cardiac Output Compared With the Direct Fick Method: A Feasibility Study, Journal of American Heart Failure, JAHA

November 4, 2024
April 13, 2021
Research
Press

Bodyport Appoints Amit Rushi as Chief Commercial Officer and Phyllis Whiteley, Ph.D. as Chair of the Board of Directors